Edwards Lifesciences Corporation (EW)

NYSE: EW · Real-Time Price · USD

83.68

+0.64 (0.77%)

At close: Jul 28, 2026, 4:00 PM EDT

84.80

+1.12 (1.34%)

After-hours: Jul 28, 2026, 7:58 PM EDT

Edwards Lifesciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,512	6,068	5,440	5,010	4,464	5,233
Revenue Growth	14.55%	11.55%	8.57%	12.23%	-14.69%	19.29%
Cost of Revenue	1,443	1,334	1,118	978.4	723.7	1,249
Gross Profit	5,069	4,733	4,322	4,032	3,740	3,984
Selling, General & Admin	2,201	2,085	1,789	1,583	1,358	1,494
Research & Development	1,091	1,079	1,053	962.9	843.6	903.1
Other Operating Expenses	301.1	304.8	101.1	177.3	40.7	-103.5
Total Operating Expenses	3,593	3,469	2,943	2,723	2,242	2,293
Operating Income	1,449	1,264	1,379	1,309	1,498	1,690
Interest Income	-	168.8	120.3	67.2	35.5	17.4
Interest Expense	-	-20.4	-19.8	-17.6	-19.2	-18.4
Other Non-Operating Income (Expense)	-169.4	-139.7	68.9	13.9	4.8	12.7
Total Non-Operating Income (Expense)	-169.4	8.7	169.4	63.5	21.1	11.7
Pretax Income	1,418	1,273	1,548	1,372	1,520	1,702
Provision for Income Taxes	439	216.9	152.1	152.4	195.5	198.9
Net Income	978.6	1,056	1,396	1,220	1,324	1,503
Minority Interest in Earnings	-1.3	-4.1	-4.9	-3	-	-
Earnings From Discontinued Operations	25	13.4	2,774	179.4	197.9	-
Net Income to Common	1,005	1,074	4,175	1,402	1,522	1,503
Net Income Growth	-75.77%	-74.28%	197.68%	-7.85%	1.25%	82.55%
Shares Outstanding (Basic)	580	585	598	607	619	623
Shares Outstanding (Diluted)	581	586	599	609	624	631
Shares Change	-1.63%	-2.25%	-1.66%	-2.37%	-1.11%	-0.11%
EPS (Basic)	1.74	1.84	6.98	2.31	2.46	2.41
EPS (Diluted)	1.74	1.83	6.97	2.30	2.44	2.38
EPS Growth	-74.96%	-73.75%	203.04%	-5.74%	2.52%	83.08%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-	1,335	289.9	642.8	973.6	1,406
Free Cash Flow Growth	-	360.50%	-54.90%	-33.98%	-30.77%	117.26%
Free Cash Flow Per Share	-	2.28	0.48	1.05	1.56	2.23
Gross Margin	77.84%	78.01%	79.46%	80.47%	83.79%	76.13%
Operating Margin	22.25%	20.84%	25.35%	26.13%	33.57%	32.30%
Profit Margin	15.03%	17.40%	25.66%	24.35%	29.66%	28.73%
FCF Margin	-	22.00%	5.33%	12.83%	21.81%	26.88%
EBITDA	1,449	1,421	1,534	1,454	1,638	1,825
EBITDA Margin	22.25%	23.42%	28.20%	29.02%	36.69%	34.88%
EBIT	1,449	1,264	1,379	1,309	1,498	1,690
EBIT Margin	22.25%	20.84%	25.35%	26.13%	33.57%	32.30%
Effective Tax Rate	30.97%	17.04%	9.82%	11.10%	12.87%	11.69%

SEC Filings: 10-K · 10-Q